Microbial Ecology in States of Health and Disease: Workshop Summary (2014)
Chapter: Appendix B: Agenda
Microbial Ecology in States of Health and Disease
March 18–19, 2013
500 Fifth Street, NW
Washington DC
|
DAY ONE: MONDAY, MARCH 18, 2013 |
|
| 7:30–8:00: | Registration and Continental Breakfast |
| 8:00–8:15: | Welcoming Remarks: David Relman, James Hughes, and Lonnie King |
| 8:15–9:00: | KEYNOTE: Indigenous microbes and the ecology of chronic diseases |
|
Martin Blaser, New York University |
|
| 9:00–9:15: | Discussion |
| 9:15–9:30: | BREAK |
| SESSION I: HOST–MICROBE INTERACTIONS IN HUMANS, ANIMALS, AND PLANTS | |
| Moderator: Rima Khabbaz, Centers for Disease Control and Prevention | |
| 9:30–10:00: | Plant–microbe interactions in root endophyte and rhizosphere communities of Populus |
|
Gerald Tuskan, Oak Ridge National Laboratory |
|
| 10:00–10:30: | Origins and maintenance of host–microbe interactions |
|
Angela Douglas, Cornell University |
|
| 10:30–11:00: | Annual cycles of extreme dietary change shape gut microbiota and their hibernator hosts |
|
Hannah Carey, University of Wisconsin, Madison |
|
| 11:00–11:30: | Symbiont microbiota and the development and maturation of the mammalian immune system |
|
Gérard Eberl, Pasteur Institute |
|
| 11:30–12:00: | Discussion |
| 12:00–1:00: | LUNCH |
| SESSION II: EMERGING INSIGHTS INTO HOST–MICROBE INTERACTIONS | |
| Moderator: David Relman, Stanford University | |
| 1:00–1:30: | Community ecology and the human vaginal microbiome |
|
Larry Forney, University of Idaho |
|
| 1:30–2:00: | Host defense and immunomodulation of mucosal candidiasis |
|
Paul Fidel, Jr., Louisiana State University |
|
| 2:00–2:30: | Interactions between the mammalian virome, disease susceptibility genes, and the phenome |
|
Herbert “Skip” Virgin, Washington University |
|
| 2:30–3:00: | BREAK |
| 3:00–3:30: | Microbial community dynamics and disruption—Health and disease in coral reefs and the human lung |
|
Forest Rohwer, San Diego State University |
|
| 3:30–4:00: | Interactions and functions of the gut microbiota in a model vertebrate host | |
|
Karen Guillemin, University of Oregon |
||
| 4:00–4:30: | The influence of the mucosal immune system and gut microbiota on inflammatory bowel diseases (IBDs) | |
|
Richard Blumberg, Harvard Medical School |
||
| 4:30–5:30: | Discussion | |
| 5:30–6:00: | Concluding Remarks | |
| 6:00: | ADJOURN DAY ONE | |
|
DAY TWO: TUESDAY, MARCH 19, 2013 |
||
| 8:00–8:30: | Registration and Continental Breakfast | |
| 8:30–8:45: | Welcoming Remarks and Summary of Day One: David Relman | |
| SESSION III: STRUCTURE AND FUNCTION OF HOSTASSOCIATED MICROBIAL COMMUNITIES | ||
| Moderator: Queta Bond, Burroughs Wellcome Fund | ||
| 8:45–9:15: | The application of ecological concepts to host-associated microbial communities | |
|
Brendan Bohannan, University of Oregon |
||
| 9:15–9:45: | Nutrition and the infant gut microbiota—Health and disease in the first 1,000 days | |
|
David Mills, University of California, Davis |
||
| 9:45–10:15: | Roles of the microbiota in the control and pathogenesis of infections | |
|
Yasmine Belkaid, National Institute of Allergy and Infectious Diseases |
||
| 10:15–10:45: | BREAK | |
| 10:45–11:15: | Host–microbe interactions and the genetic architecture of IBD and other complex diseases | |
|
Ramnik Xavier, Massachusetts General Hospital |
||
| 11:15–11:45: | Host–mycobiome interactions in gut homeostasis and pathogenesis |
|
David Underhill, Cedars-Sinai Medical Center |
|
| 11:45–12:15: | Discussion |
| 12:15–1:15: | LUNCH |
| SESSION IV: RESEARCH CHALLENGES AND OPPORTUNITIES | |
| Moderator: Jesse Goodman, Food and Drug Administration | |
| 1:15–1:45: | Metabolism, interspecies interactions, and novel approaches to disease diagnostics and treatment |
|
Michael Fischbach, University of California, San Francisco |
|
| 1:45–2:15: | Fecal transplantation as a treatment option for recurrent Clostridium difficile infection |
|
Josbert J. Keller, University of Amsterdam |
|
| 2:15–2:45: | BREAK |
| 2:45–3:15: | Innate antimicrobial mechanisms in disease prevention and treatment |
|
Michael Zasloff, Georgetown University |
|
| 3:15–3:45: | The skin microbiome and chronic disease states |
|
Julie Segre, National Human Genome Research Institute |
|
| 3:45–4:30: | Discussion |
| 4:30–4:45: | Concluding Remarks |
| 4:45: | ADJOURN |
